Editorial Board
Sher Zaman Safi
University of Malaya · Malaysia
Editorial leadership for Journal of Antioxidant Activity ISSN 2471-2140
Research interests
- Molecular Cell Biology
- Virology
- Immunology Epigenetics
- Gene Regulations In Diabetes Methylation
- Acetylation Analysis Of Different Genes
- Including Cell Cycle Responsible Genes In Diabetic Complications Investigating Dnmts
- The Transcription Factors Like Stat3
- P300
- Ap-1
- Sp1 Neurosciences
- Stem Cells
- Differentiation
- Neuronal Development Vaccines
- Immunotherapeutic Drug Designing Molecular Biotechnology (Health &Amp; Diseases) Aging Medical Biotechnology (Antimicrobial Agents
- Chemotherapy) Forensic Biotechnology (Dna
- Rna
- Plasmid
- &Amp; Protein Profiling) Industrial Biotechnology (Biofermentation
- Biomanufacture &Amp; Biodegradation)
Biography
- I am Dr Sher Zaman Safi from the Department of Medicine, University of Malaya, Kuala Lumpur Malaysia.
- I just Finished My PhD in Molecular mechanisms of Diabetic complications.
- I had received my Masters and MPhil in Molecular Biology/Biochemistry and Clinical/Molecular Virology respectively.
- I have been working and studying in Ajou University South Korea, National University of Science and Technology Pakistan and University of Malaya.
- Currently I am Working as a researcher in the Department of Medicine, University of Malaya but in couple of months I will secure the position of senior research fellow here in the same University.
- I have been working as a reviewer for atleast 10 international journals.
- I am also one of the Editorial board members for the the Asian Pacific Journal of Tropical Biomedicine since last 3 years.
- I want to serve as an Editorial board member for your Journal(s).
- My expertise includes Biology in general and Genetics, Molecular Biology, Clinical biology, Cell signaling, Gene regulation and Apoptosis in particular.
Considering JAA for your work?
This journal is guided by Sher Zaman Safi (University of Malaya) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.